San Diego, CA -- (SBWIRE) -- 11/18/2014 -- An investigation on behalf of current long-term investors in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Alexion Pharmaceuticals.

Investors who purchased shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and currently hold any of those NASDAQ:ALXN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Alexion Pharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Alexion Pharmaceuticals, Inc. reported that its annual Total Revenue rose from over $1.13 billion in 2012 to over $1.55 billion in 2013 while its respective Net Income declined from $254.82 million to $252.90 million. Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) grew from $88.49 per share in June 2013 to as high as $19.570 per share on November 11, 2014.

On November 14, 2014, NASDAQ:ALXN shares declined from $18.06 per share.

Those who purchased shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com